ProjectUpdated on 27 August 2025
Microbiome-driven Smart Health Platform for Belt & Road Wellness Integration
About
We are developing a microbiome‑driven Smart Health Platform that leverages advanced gut microbiome profiling, AI‑powered diagnostics, and personalized interventions to enhance wellness across Belt & Road markets. This platform enables early detection of digestive and metabolic imbalances and delivers tailored recommendations for dietary, prebiotic/probiotic, and lifestyle interventions.
What We Offer
-
Microbiome assays using the latest Next Generation Sequencing technology to get the most insighful information on the gut microbiome profile.
-
AI‑enhanced analytical engine delivering actionable health insights with predictive modeling.
-
Modular digital framework enabling integration with healthcare systems, wellness providers, and logistics partners.
Partnership Opportunities
We are seeking:
-
Strategic Investors for scaling platform deployment across Asia, Middle East, and emerging B&R markets.
-
Institutional/Regional Distribution Partners for market rollout through medical networks, wellness chains, or public health systems.
-
Co‑development Partners (service providers, R&D, university tech hubs) to adapt diagnostics for local healthcare infrastructure and regulatory frameworks.
Alignment with Belt & Road Priorities
This platform aligns directly with the Summit’s focus on Innovation & Technology, Urban & Health Development, and Green / Health‑tech commercialization, offering scalable, people‑centered benefits across multiple markets.
Deployment Scope
We plan pilot launches in ASEAN and Middle East regions, with phased expansion leveraging healthcare and professional services ecosystems. Future iterations may include logistics‑integrated sample processing and green supply chain partners to align with ESG goals.
Why Now
The rising global focus on preventive health and digital diagnostics, particularly in Belt & Road economies, offers timely entry points for innovative health‑tech solutions. With validated tech in hand, we are ready to collaborate with like‑minded stakeholders to deliver transformative health outcomes.
Project Location
- China (Hong Kong)
Project Format
- Private Project
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Project Planning
Main Project Sector
- Technology
Technology
- Bio-Tech
Total Project Value
- 500,001 to 1,000,000 USD
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Interested Format of Cooperation
- Joint Venture
- Open for Negotiation
Preferred Financing Model
- Open for negotiation
Previous Funding Stage
- Seed & Pre-Series
Main Service(s) Required
- Professional Services
Attached files
Organisation
Hong Kong, China (Hong Kong)
Similar opportunities
Project
GUTolution AI-Driven Micrbiome Testing
- Yes
- Bio-Tech
- Technology
- E-commerce
- IP Related
- Private Project
- Project Planning
- Health Technology
- Health Facilities
- Seed & Pre-Series
- Medical Technology
- Business Valuation
- Professional Services
- 500,001 to 1,000,000 USD
Gabriel Chan
Head of Partnerships at GUTolution Limited
Hong Kong, China (Hong Kong)
Project
KetoAir Global Expansion: Seeking Distribution Partners for Revolutionary Breath Health Monitoring
- No
- IPO
- Bio-Tech
- Operations
- Technology
- Tax Advisory
- Manufacturing
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Financial Advisory
- Open for negotiation
- Professional Services
- Corporate Intelligence
- Market Entry Strategic Analysis
Nelson Yiu
Ecommerce and Business Development Manager at Qi Diagnostics Limited
Hong Kong, China (Hong Kong)
Project
- No
- Bio-Tech
- Operations
- Technology
- Private Project
- Seed & Pre-Series
- Medical Technology
- Professional Services
Kathy Kwan
Head of Makreting at GUTolution Limited
Hong Kong, China (Hong Kong)